Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 95
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Synthesis of a Kidney Cancer Drug

    We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

    Can we utilize natural bat colony behavior as a vaccination strategy?

    Bats are one of the most prolific and ecologically important groups of mammals on the planet, but they are...

    Can we prevent the transmission of BRCA mutations?

    Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

    Backer Badge Funded